{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:33:25Z","timestamp":1787758405755,"version":"build-2784847793"},"reference-count":43,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background\/Objectives: Veterinary vaccine manufacturing is essential for controlling transboundary animal diseases, strengthening animal health systems, and supporting livestock development, particularly in Southeast Asia where livestock production continues to expand. However, modernization toward Pharmaceutical Inspection Co-operation Scheme (PIC\/S) Good Manufacturing Practice (GMP) compliance remains challenging because it requires coordinated development across regulatory, technical, organizational, financial, and governance domains. This study aimed to develop an evidence-informed strategic framework for veterinary vaccine manufacturing modernization through a structured and systematically documented framework development methodology integrating multidisciplinary evidence and practice-informed implementation experience. Methods: An evidence-informed framework development study was conducted through the multidisciplinary integration of multiple evidence sources, including international regulatory guidance, peer-reviewed scientific literature, multidisciplinary feasibility assessment, and practice-informed implementation experience derived from a government-commissioned consultancy project. Framework development followed a structured methodology comprising evidence collection, evidence categorization, multidisciplinary evidence synthesis, framework development, iterative refinement, and expert-informed validation. Only generalized methodological principles and potentially transferable implementation knowledge were incorporated to ensure confidentiality of project-specific information. Results: Multidisciplinary evidence synthesis identified ten evidence domains encompassing regulatory, technical, organizational, economic, legal, environmental, governance, workforce, infrastructure, and implementation considerations. These domains were translated through a structured process into an evidence-informed strategic framework organized around four sequential modernization phases\u2014Design, Construction, Validation, and Continuous Improvement\u2014supported by cross-cutting strategic enablers. Iterative refinement through expert review, technical consultation, and implementation verification strengthened the framework\u2019s scientific consistency, regulatory alignment, and practical applicability. Conclusions: Veterinary vaccine manufacturing modernization should be regarded as a multidisciplinary organizational transformation rather than solely as an infrastructure or engineering project. Beyond proposing a strategic framework, this study provides a transparent, systematically documented and traceable methodology for translating multidisciplinary evidence into strategic decision-support tools. The proposed framework may assist governments, regulatory authorities, vaccine manufacturers, and researchers in developing evidence-informed modernization strategies for veterinary biological manufacturing systems, particularly in low- and middle-income countries, subject to adaptation to specific regulatory, technical, institutional, and resource contexts.<\/jats:p>","DOI":"10.3390\/vaccines14090738","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:04:32Z","timestamp":1787756672000},"page":"738","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Developing an Evidence-Informed Strategic Framework for Veterinary Vaccine Manufacturing Modernization Toward PIC\/S GMP Compliance"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9717-233X","authenticated-orcid":false,"given":"Terdsak","family":"Yano","sequence":"first","affiliation":[{"name":"Department of Veterinary Medicine, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8877-661X","authenticated-orcid":false,"given":"Thanaporn","family":"Eiamsam-ang","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tossapond","family":"Kewprasopsak","sequence":"additional","affiliation":[{"name":"School of Economics, Faculty of Economics, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panuwat","family":"Yamsakul","sequence":"additional","affiliation":[{"name":"Department of Veterinary Medicine, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50200, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"ref_1","unstructured":"Food and Agriculture Organization of the United Nations (FAO) (2018). World Livestock: Transforming the Livestock Sector Through the Sustainable Development Goals, FAO."},{"key":"ref_2","unstructured":"Organisation for Economic Co-operation and Development (OECD), and Food and Agriculture Organization of the United Nations (FAO) (2024). OECD\u2013FAO Agricultural Outlook 2024\u20132033, OECD Publishing."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.prevetmed.2013.07.013","article-title":"The economic impacts of foot-and-mouth disease\u2014What are they, how big are they and where do they occur?","volume":"112","author":"Rushton","year":"2013","journal-title":"Prev. Vet. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev-animal-021419-083741","article-title":"African swine fever epidemiology and control","volume":"8","author":"Dixon","year":"2020","journal-title":"Annu. Rev. Anim. Biosci."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Tuppurainen, E., Dietze, K., Wolff, J., Bergmann, H., Beltran-Alcrudo, D., Fahrion, A., Lamien, C.E., Busch, F., Sauter-Louis, C., and Conraths, F.J. (2021). Review: Vaccines and vaccination against lumpy skin disease. Vaccines, 9.","DOI":"10.3390\/vaccines9101136"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1099\/vir.0.025841-0","article-title":"Global distribution of peste des petits ruminants virus and prospects for improved diagnosis and control","volume":"91","author":"Banyard","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.provac.2011.10.009","article-title":"Veterinary vaccines and their importance to animal health and public health","volume":"5","author":"Roth","year":"2011","journal-title":"Procedia Vaccinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1016\/j.vaccine.2017.06.003","article-title":"The complexity and cost of vaccine manufacturing\u2014An overview","volume":"35","author":"Plotkin","year":"2017","journal-title":"Vaccine"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1586\/erv.09.23","article-title":"Reaching international GMP standards for vaccine production: Challenges for developing countries","volume":"8","author":"Milstien","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"ref_10","unstructured":"(2023). Pharmaceutical Inspection Co-operation Scheme (PIC\/S). Guide to Good Manufacturing Practice for Medicinal Products (PE 009-17), PIC\/S."},{"key":"ref_11","unstructured":"World Health Organization (2) (2021). WHO Expert Committee on Biological Standardization: Seventy-Second Report. Annex 2: WHO Good Manufacturing Practices for Biological Products (WHO Technical Report Series No. 1025), World Health Organization."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2020529","DOI":"10.1080\/21645515.2021.2020529","article-title":"Capacity Building for Vaccine Manufacturing Across Developing Countries: The Way Forward","volume":"18","author":"Kumraj","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"7288","DOI":"10.1016\/j.vaccine.2022.10.044","article-title":"Sustainable vaccine manufacturing in low- and middle-income countries","volume":"40","author":"Hayman","year":"2022","journal-title":"Vaccine"},{"key":"ref_14","unstructured":"Coalition for Epidemic Preparedness Innovations (CEPI) (2023). 100 Days Mission: Implementing a New Paradigm for Pandemic Vaccine Development and Manufacturing, CEPI."},{"key":"ref_15","unstructured":"Sterman, J.D. (2000). Business Dynamics: Systems Thinking and Modeling for a Complex World, Irwin\/McGraw-Hill."},{"key":"ref_16","unstructured":"European Medicines Agency (2022). EudraLex\u2014The Rules Governing Medicinal Products in the European Union, Volume 4: EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use, European Commission."},{"key":"ref_17","unstructured":"U.S. Food and Drug Administration (2011). Guidance for Industry: Process Validation: General Principles and Practices, FDA."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1471-1842.2009.00848.x","article-title":"A typology of reviews: An analysis of 14 review types and associated methodologies","volume":"26","author":"Grant","year":"2009","journal-title":"Health Inf. Libr. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tvjl.2007.11.009","article-title":"Veterinary vaccine development from an industrial perspective","volume":"178","author":"Heldens","year":"2008","journal-title":"Vet. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/104063870001200102","article-title":"Porcine circoviruses: A review","volume":"12","author":"Allan","year":"2000","journal-title":"J. Vet. Diagn. Investig."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"20961","DOI":"10.1074\/jbc.M411379200","article-title":"Mycobacterium tuberculosis heat shock proteins use diverse Toll-like receptor pathways to activate pro-inflammatory signals","volume":"280","author":"Bulut","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.imbio.2005.05.015","article-title":"Synthetic bacterial lipopeptide analogs: Structural requirements for adjuvanticity","volume":"210","author":"Ghielmetti","year":"2005","journal-title":"Immunobiology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2001.tb02680.x","article-title":"Prospects for development of a vaccine against the West Nile virus","volume":"951","author":"Monath","year":"2001","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"ref_24","unstructured":"European Commission (1995). The Rules Governing Medicinal Products in the European Community. Volume VII: Guidelines for the Testing of Veterinary Medicinal Products, Office for Official Publications of the European Communities. Catalogue No. CO-86-94-383-EN-C."},{"key":"ref_25","unstructured":"European Parliament, and Council of the European Union (2001). Directive 2001\/83\/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code Relating to Medicinal Products for Human Use. Off. J. Eur. Communities, L311, 67\u2013128."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13012-015-0242-0","article-title":"Making sense of implementation theories, models and frameworks","volume":"10","author":"Nilsen","year":"2015","journal-title":"Implement. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/chp.47","article-title":"Lost in knowledge translation: Time for a map?","volume":"26","author":"Graham","year":"2006","journal-title":"J. Contin. Educ. Health Prof."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Thomas, J., and Harden, A. (2008). Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med. Res. Methodol., 8.","DOI":"10.1186\/1471-2288-8-45"},{"key":"ref_29","unstructured":"Committee on Publication Ethics (COPE) (2017). COPE Core Practices, COPE. Available online: https:\/\/publicationethics.org\/core-practices."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.amepre.2012.05.024","article-title":"Bridging research and practice: Models for dissemination and implementation research","volume":"43","author":"Tabak","year":"2012","journal-title":"Am. J. Prev. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: A consolidated framework for advancing implementation science","volume":"4","author":"Damschroder","year":"2009","journal-title":"Implement. Sci."},{"key":"ref_32","unstructured":"Meadows, D.H. (2008). Thinking in Systems: A Primer, Chelsea Green Publishing."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/1468-0009.00206","article-title":"Improving the quality of health care in the United Kingdom and the United States: A framework for change","volume":"79","author":"Ferlie","year":"2001","journal-title":"Milbank Q."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1258\/1355819054308530","article-title":"Realist review\u2014A new method of systematic review designed for complex policy interventions","volume":"10","author":"Pawson","year":"2005","journal-title":"J. Health Serv. Res. Policy"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-5908-3-1","article-title":"Evaluating the successful implementation of evidence into practice using the PARIHS framework: Theoretical and practical challenges","volume":"3","author":"Kitson","year":"2008","journal-title":"Implement. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.PHH.0000311888.06252.bb","article-title":"A glossary for dissemination and implementation research in health","volume":"14","author":"Rabin","year":"2008","journal-title":"J. Public Health Manag. Pract."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1748-5908-3-36","article-title":"Healthcare professionals\u2019 intentions and behaviours: A systematic review of studies based on social cognitive theories","volume":"3","author":"Godin","year":"2008","journal-title":"Implement. Sci."},{"key":"ref_38","unstructured":"Bloom, B.R., and Lambert, P.-H. (2016). Vaccine production: Main steps and considerations. The Vaccine Book, Academic Press. [2nd ed.]."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1080\/14760584.2016.1205492","article-title":"Manufacturing DTaP-based combination vaccines: Industrial challenges around essential public health tools","volume":"15","author":"Vidor","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1016\/j.vaccine.2012.02.064","article-title":"Cost of production of live attenuated dengue vaccines: A case study of the Instituto Butantan, S\u00e3o Paulo, Brazil","volume":"30","author":"Mahoney","year":"2012","journal-title":"Vaccines"},{"key":"ref_41","unstructured":"Pisano, G.P. (1996). The Development Factory: Unlocking the Potential of Process Innovation, Harvard Business School Press."},{"key":"ref_42","unstructured":"U.S. Department of Defense (2026, February 17). Report on Biological Warfare Defense Vaccine Research and Development Programs, Available online: http:\/\/archive.defense.gov\/pubs\/ReportonBiologicalWarfareDefenseVaccineRDPrgras-July2001.pdf."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Checkland, P. (1999). Systems Thinking, Systems Practice, John Wiley & Sons.","DOI":"10.1093\/oso\/9780198775331.003.0004"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/738\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:12:18Z","timestamp":1787757138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":43,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["vaccines14090738"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14090738","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]}}}